Literature DB >> 18805911

Acylation stimulating protein but not complement C3 associates with metabolic syndrome components in Chinese children and adolescents.

Ponce Cedric Fouejeu Wamba1, Jie Mi, Xiao-Yuan Zhao, Mei-Xian Zhang, Yu Wen, Hong Cheng, Dong-Qing Hou, Katherine Cianflone.   

Abstract

OBJECTIVE: Childhood obesity is increasing worldwide and is increasingly associated with metabolic syndrome (MetS). Our aim was to examine acylation stimulating protein (ASP) and its precursor complement C3, in normal, overweight, and obese Chinese children and adolescents, and the relationships with body size, blood parameters, pubertal development, family environment, and MetS.
METHODS: Children and adolescents (n=1603) from 6 to 18 years, boys (n=873) and girls (n=730), including normal weight (n=603), overweight (n=291) and obese (n=709) were assessed for body size parameters, pubertal development, blood lipids, glucose, insulin, ASP, and C3.
RESULTS: ASP levels were increased in overweight and obese versus normal weight (P<0.001), while C3 showed little variation. This effect of overweight/obesity remained throughout early stages when boys and girls were separated by pubertal development or age, although age and pubertal status itself had no effect. Separation based on ASP quintiles demonstrated significant associations with blood cholesterol, triglyceride, low-density lipoprotein cholesterol (LDL-Chol), glucose, insulin, and homeostatic model assessment of insulin resistance in boys, and LDL-Chol, high-density lipoprotein cholesterol, and glucose in girls. A positive correlation with mother's body mass index in boys and girls (P=0.002 and P=0.014 respectively) as well as birth weight (P<0.001) was noted. MetS was strongly associated with increased ASP, the presence of a single MetS factor (especially hypertension, central obesity, or hyperglycemia) was associated with increased ASP.
CONCLUSION: Changes in the plasma adipokine ASP in early obesity are associated with blood lipid and glucose modifications, family environment, and distinct MetS risk factors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18805911     DOI: 10.1530/EJE-08-0467

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  5 in total

Review 1.  The role of complement system in adipose tissue-related inflammation.

Authors:  Sonia I Vlaicu; Alexandru Tatomir; Dallas Boodhoo; Stefan Vesa; Petru A Mircea; Horea Rus
Journal:  Immunol Res       Date:  2016-06       Impact factor: 2.829

2.  Plasma complement components and activation fragments: associations with age-related macular degeneration genotypes and phenotypes.

Authors:  Robyn Reynolds; M Elizabeth Hartnett; John P Atkinson; Patricia C Giclas; Bernard Rosner; Johanna M Seddon
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-08-06       Impact factor: 4.799

3.  Elevated serum complement factors 3 and 4 are strong inflammatory markers of the metabolic syndrome development: a longitudinal cohort study.

Authors:  Zhenfang Liu; Qin Tang; Jing Wen; Yan Tang; DaMin Huang; Yuzhen Huang; Jinling Xie; Yawen Luo; Min Liang; Chunlei Wu; Zheng Lu; Aihua Tan; Yong Gao; Qiuyan Wang; Yonghua Jiang; Ziting Yao; Xinggu Lin; Haiying Zhang; Zengnan Mo; Xiaobo Yang
Journal:  Sci Rep       Date:  2016-01-04       Impact factor: 4.379

4.  Complement C3 and C4, but not their regulators or activated products, are associated with incident metabolic syndrome: the CODAM study.

Authors:  Ying Xin; Elisabeth Hertle; Carla J H van der Kallen; Casper G Schalkwijk; Coen D A Stehouwer; Marleen M J van Greevenbroek
Journal:  Endocrine       Date:  2018-08-21       Impact factor: 3.633

5.  Associations of immunological factors with metabolic syndrome and its characteristic elements in Chinese centenarians.

Authors:  Shihui Fu; Yao Yao; Faqin Lv; Fu Zhang; Yali Zhao; Fuxin Luan
Journal:  J Transl Med       Date:  2018-11-19       Impact factor: 5.531

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.